Feed Preview

Ebola Vaccine

Ebola Vaccine diagram by Nixx Photography, Shutterstock
Nixx Photography, Shutterstock

The recent ebola outbreak in west Africa has stressed the need for advances in research to develop a vaccine against this deadly virus. Much progress has been made in pre-clinical and clinical studies and future vaccines for the ebola virus look promising. Here is the latest research on ebola vaccines.

Top 20 most recent papers
Molecular Biology and Evolution

Online Bayesian phylodynamic inference in BEAST with application to epidemic reconstruction

Molecular Biology and EvolutionFebruary 27, 2020
Mandev S GillGuy Baele

Antibody Teamwork against Ebola Virus Disease

ImmunityFebruary 21, 2020
Matthias Zehner, Florian Klein
Physiological Reviews

From Ancient to Emerging Infections: The Odyssey of Viruses in the Male Genital Tract

Physiological ReviewsFebruary 8, 2020
Anna Le TortorecNathalie Dejucq-Rainsford

Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription

MBioFebruary 27, 2020
Yuki TakamatsuStephan Becker
Intensive Care Medicine

Treatment of Ebola-related critical illness

Intensive Care MedicineFebruary 15, 2020
Peter KiizaR A Fowler
Emerging Microbes & Infections

Delayed recognition of Ebola virus disease is associated with longer and larger outbreaks

Emerging Microbes & InfectionsFebruary 5, 2020
M Jeremiah MatsonVincent J Munster
Emerging Infectious Diseases

Update on Ebola Treatment Center Costs and Sustainability, United States, 2019

Emerging Infectious DiseasesFebruary 26, 2020
Jocelyn J HersteinShawn G Gibbs
The Journal of Infectious Diseases

Serological Evidence for Henipa-like and Filo-like Viruses in Trinidad Bats

The Journal of Infectious DiseasesFebruary 9, 2020
Jonathan E SchulzVincent J Munster
Pediatric Emergency Care

Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Tasks

Pediatric Emergency CareFebruary 26, 2020
Mark D AdlerBest Pharmaceuticals for Children Act–Pediatric Trials Network¶¶

Rescue Ebola Patients in silico

bioRxivFebruary 10, 2020
Gang ZhaoMichael Meyer-Hermann
Pharmacology & Therapeutics

Favipiravir, an anti-influenza drug against life-threatening RNA virus infections

Pharmacology & TherapeuticsFebruary 26, 2020
Kimiyasu Shiraki, Tohru Daikoku
Drugs of Today

The year's new drugs and biologics 2019

Drugs of TodayFebruary 15, 2020
A I GraulL Sorbera
Biochemical and Biophysical Research Communications

Crystal structure of the Měnglà virus VP30 C-terminal domain

Biochemical and Biophysical Research CommunicationsFebruary 26, 2020
Shishang DongXiaochun Qin

See more papers from this feed

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

© 2020 Meta ULC. All rights reserved